Variable | CTO | PR (95%CI) | p | |
---|---|---|---|---|
Yes | No | |||
Age, n (%) | ||||
≥ 60 years | 12 (85.7) | 2 (14.3) | 1.125 (0.879–1.439) | 0.730 |
< 60 years | 64 (76.2) | 20 (23.8) | ||
Gender, n (%) | ||||
Male | 72 (80.9) | 17 (19.1) | 1.820 (0.867–3.819) | 0.025* |
Female | 4 (44.4) | 5 (55.6) | ||
Diabetes mellitus, n (%) | ||||
Yes | 21 (67.7) | 10 (32.3) | 0.825 (0.631–1.080) | 0.126* |
No | 55 (82.1) | 12 (17.9) | ||
Hypertension, n (%) | ||||
Yes | 43 (75.4) | 14 (24.6) | 0.937 (0.758–1.159) | 0.629 |
No | 33 (80.5) | 8 (19.5) | ||
Dyslipidemia, n (%) | ||||
Yes | 62 (78.5) | 17 (21.5) | 1.065(0.794–1.429) | 0.760 |
No | 14 (73.7) | 5 (26.3) | ||
Previous ACS, n (%) | ||||
Yes | 7 (70.0) | 3 (30.0) | 0.893 (0.585–1.362) | 0.689 |
No | 69 (78.4) | 19 (21.6) | ||
Antiplatelet, n (%) | ||||
Yes | 4 (80.0) | 1 (20.0) | 1.033 (0.656–1.6571) | 0.893 |
No | 72 (77.4) | 21 (22.6) | ||
Statin use, n (%) | ||||
No | 66 (75.0) | 22 (25.0) | 0.750 (0.664–0.847) | 0.111* |
Yes | 10 (100.0) | 0 (0.0) | ||
Smoking, n (%) | ||||
Yes | 69 (83.1) | 14 (16.9) | 1.781 (1.025–3.095) | 0.004* |
No | 7 (46.7) | 8 (53.3) | ||
Family history of CAD, n (%) | ||||
Yes | 15 (75.0) | 5 (25.0) | 0.959 (0.725–1.269) | 0.768 |
No | 61 (78.2) | 17 (21.8) | ||
Median NLR (IQR) | 7.81 (6.38–11.85) | 3.38 (2.32–5.43) | N/A | < 0.001a |
NLR | ||||
≥ 6.42 | 56 (91.8) | 5 (8.2) | 1.698 (1.359–2.311) | < 0.001* |
< 6.42 | 20 (54.1) | 17 (45.9) |